Oklahoma Cannabis: 1,398 Dispensaries, $2.11/g Flower, and a Criminal Diversion Problem

Oklahoma passed SQ 788 in 2018 with no qualifying condition list — patients need only a recommendation from an OMMA-registered physician in good standing. The result is a medical program that functions as adult use in everything but name: $2.11/g flower, 1,398 licensed dispensaries, and the lowest legal cannabis price of any state in this dataset. But behind the legitimate retail layer sits something else entirely: 85 million plants' worth of licensed production unaccounted for in Metrc, a congressional hearing on national security implications, and a $1.5 billion criminal diversion ring dismantled in January 2026. Oklahoma's story is two markets operating simultaneously under the same license framework.

Market Overview

Oklahoma passed State Question 788 in June 2018. First patient sales launched October 2018. There is no adult-use program — SQ 820, which would have created one, failed at the ballot in March 2023 (~61.7% against). The market is regulated by the Oklahoma Medical Marijuana Authority (OMMA), linked directly to OMMA's NCS Analytics transparency dashboard.

Key metrics:

• 1,398 licensed dispensaries statewide (late April 2026 per NCS; OMMA's April 1 licensing report showed 1,417; down from a peak of 2,893 in March 2023)
• 2025 retail sales: $671.1 million (medicinal only; NCS Analytics/Metrc data)
• $2.11/g flower (March 2026, calculated from NCS retail sales ÷ pounds sold)
• 7% excise tax + 4.5% state sales tax + local (~11.5–12% minimum; higher in localities with additional taxes)
• ~$2.36/g all-in (state taxes only; higher in localities with additional taxes)
• $100 state card fee (2-year license; $20 for Medicaid/Medicare/100% disabled veterans)
• No qualifying condition list — recommendations require an OMMA-registered physician in good standing following accepted medical standards

Flower Pricing

Oklahoma's price per gram is derived directly from NCS Analytics Metrc data: March 2026 flower & bud retail sales of $19,056,604 divided by 19,947 lbs sold (9,047,268 grams) = $2.11/g. This is not an estimate — it is a derived figure from mandatory seed-to-sale reporting.

Oklahoma's $2.36/g all-in is the lowest consumer price of any legal market in this dataset — cheaper than Michigan's $3.46, cheaper than Colorado's $3.66. The black market in Oklahoma has no price advantage. At these levels, the only consumers still buying from unlicensed sources are doing so for reasons unrelated to economics.

Tax Structure

• 7% cannabis excise tax (SQ 788; applied at retail to patients)
• 4.5% state sales tax
• Local option taxes (vary by municipality)
• Combined burden: ~11.5–12% minimum; higher in some cities
• Medical card: $100 state fee (2-year license) + physician recommendation (~$75–200)
• Medicaid/Medicare patients: $20 reduced state fee

Oklahoma's tax structure is among the most competitive in the dataset. The 7% excise — the lowest state cannabis excise of any program studied — was set by voter initiative in SQ 788 and has remained unchanged. The total burden of ~12% is well below the threshold where markets fail to achieve full displacement.

The two-year card cycle means annual patient cost is approximately $50/year in state fees plus $37–100/year in physician recommendation costs — roughly $90–150/year total. At $2.11/g and ~14 grams/month of typical consumption, the card break-even is less than 4 days of savings versus the black market. Nearly every regular consumer has strong economic incentive to hold a card.

Total Addressable Market

Oklahoma's adult population is approximately 3.1 million. Applying the empirically validated consumption baseline of 18% participation at 1.0 gram per day:

• 3.1 million adults 21+
• 558,000 estimated regular consumers (18%)
• 203.7 million grams annual demand
• TAM at $2.11/g: ~$429.8 million

Actual 2025 retail revenue of $671.1M against the $429.8M TAM implies approximately 156% capture. Unlike Michigan’s export bubble (legal cannabis flowing to prohibition neighbors at a price premium) or Maine’s tourism surplus, Oklahoma’s overcapture does not reflect legitimate cross-border demand. It reflects industrial-scale criminal diversion operating behind fraudulent licenses — a problem of a different order entirely.

The Criminal Infrastructure Problem

Oklahoma’s open licensing structure attracted something beyond ordinary market participants. In September 2025 congressional testimony, OBN Director Donnie Anderson stated that licensed grow sites reported 87,210,960 plants between 2024 and 2025, while dispensaries sold only 1,689,601 pounds of cannabis over that period. Using a one-pound-per-plant assumption, Anderson estimated that more than 85 million plants’ worth of product is unaccounted for — an official law enforcement estimate of the diversion problem, not a completed independent production audit.

The mechanism is the straw ownership scheme. Non-residents — primarily Chinese nationals connected to Fujianese organized crime networks — paid Oklahoma residents to fraudulently obtain cultivation licenses, then used those licensed grows to produce cannabis at industrial scale and divert it entirely to out-of-state black markets. AG Drummond established the Organized Crime Task Force (OCTF) in 2023 specifically to address the problem. Cumulative OCTF results through October 2025: more than 7,000 illegal operations shut down, 329,075+ plants seized, 152,612+ pounds of processed marijuana, 26,520+ pounds of THC concentrate, 79+ arrests, 153 criminal cases filed. For context, Drummond stated that Oklahoma had more than 9,000 licensed grow operations when he took office — fewer than 1,200 remained as of early 2026.

The single largest documented operation is Operation Blunt Force (initiated March 2024, 20 arrests January 2026) — a multi-state criminal enterprise led by Hao Tong Chen of New York City, characterized by the AG as a $1.5 billion, 1-million-pound diversion ring using 14 licensed Oklahoma cannabis businesses as cover, with wire transfers to China. As recently as April 9, 2026, OCTF raided two grows and two processing facilities in Tulsa and Claremore, seizing 58,920 plants and 1,350 pounds of processed marijuana, with operators accused of running straw ownership schemes since 2024.

The U.S. House Homeland Security Subcommittee held a hearing in September 2025 characterizing the criminal network operations as a national security threat — grows have been documented near military installations including the McAlester ammunition facility. The Frontier/ProPublica investigation documented a persistent pattern: after raids, criminal operations consolidate at other licensed sites. The license is the asset being exploited, not the land.

This context reframes the 156% capture figure entirely. Oklahoma’s $671M in legal retail represents the legitimate medical dispensary layer. The 85 million unaccounted-for plants represent a parallel criminal production layer operating behind licensed facades. The $2.11/g retail price reflects genuine competition among legitimate dispensaries. The criminal grows are not competing in the Oklahoma retail market — they are exporting wholesale product to black markets in Texas, New York, Nevada, and Georgia where prices are multiples higher.

The De Facto Adult-Use Structure

Oklahoma's SQ 788 contains no list of qualifying conditions. Patients need a recommendation from an OMMA-registered physician in good standing — and physician recommendations are available statewide, online, for as little as $75. The practical effect is that any Oklahoma resident who wants a medical cannabis card can obtain one with minimal friction.

OMMA confirmed the consequence in its own commissioned study: Oklahoma has 32 times more regulated medical cannabis supply than is necessary to meet demand from licensed patients. That figure — from the regulator's own third-party analysis — is not a market failure. It is the predictable outcome of open licensing with no supply cap in a state where virtually the entire adult population can qualify for the program.

The 1,398 active dispensaries represent a significant market correction from the March 2023 peak of 2,893. OMMA's response to oversupply — tiered license fee increases, stricter compliance requirements, enforcement of renewal deadlines, and a moratorium on new licenses since August 2022 — has driven consolidation since 2023. The weaker operators are exiting. The market structure is rationalizing toward a sustainable density, though slowly.

Revenue Trend

Revenue peaked in 2024 and declined slightly in 2025 — the same price-outpacing-volume dynamic visible in New Mexico and Oregon. The decline is modest relative to the price compression, confirming that volume growth is partially absorbing the revenue impact. The 2022 figure is partial (Metrc tracking began June 2022) and understates the full year.

Dispensary Density

At 45.1 dispensaries per 100K adults, Oklahoma has the second-highest density in the dataset behind New Mexico. Average revenue per store of $480K annually is the lowest — reflecting both the competitive pricing and the sheer number of licensees dividing a $671M market. The consolidation math is straightforward: at $480K/store, the average Oklahoma dispensary generates less than $40K/month. Operators covering rent, payroll, compliance, and inventory at those margins are functionally insolvent. The exit wave is structural, not cyclical.

Home Cultivation

Oklahoma permits registered patients to cultivate up to 6 mature plants and 6 seedlings — a patient right, not a household cap. At any legal retail price below ~$3/g, home cultivation economics become marginal — the time, equipment, and utility cost of a grow rarely pencil out below that threshold. At $2.11/g retail, growing your own in Oklahoma is economically irrational for most consumers. The cultivation right exists but has no measurable effect on market capture.

What the CHS Literature Missed

The only Oklahoma government source that addresses CHS directly is an Oklahoma Department of Corrections patient education document — a Cannabis Use Disorder basics handout issued August 2024 for incarcerated patients. It describes CHS clinically: "a condition that causes frequent vomiting. It can happen in people who have been using cannabis regularly for at least a year." No prevalence figure. The document is directed at a captive population of documented heavy users — the highest-risk group for any frequency-dependent condition — and still makes no claim about how common CHS is among them.

OMMA's own consumer health materials, dispensary compliance resources, and patient licensing documentation do not mention CHS. This is the regulator overseeing a program with 1,398 dispensaries, approximately 300,000 active patients, and $671M in annual sales — and CHS does not appear in any consumer-facing guidance.

Oklahoma's $2.11/g pricing provides the most direct behavioral test in the dataset. High-end CHS prevalence estimates range from a 2018 emergency department convenience sample finding 32.9% among frequent ED visitors — a heavily pre-selected population — to a 2026 preprint reporting CHS-like symptoms in 17.8% of daily users. A systematic review of published CHS cases found that 96.8% experienced complete resolution of symptoms after stopping cannabis. That cessation requirement is the key behavioral test: if even the conservative end of CHS prevalence estimates were accurate for the general daily-user population, the market with the lowest prices — drawing the highest per-capita volume of heavy users — should show the most pronounced demand destruction signal as CHS sufferers cycle out. Instead Oklahoma shows 156% capture with revenue holding near peak. The consumption data is inconsistent with mass-prevalence CHS at any price point, and most inconsistent at the lowest one.

The Bottom Line

Oklahoma built the most price-competitive legal cannabis market in the country without intending to. A no-condition-list medical program plus open licensing plus no supply cap equals $2.11/g flower, 45 dispensaries per 100K adults, and a regulator commissioning studies about 32x oversupply. The black market has no remaining price advantage and minimal access advantage. Oklahoma has achieved black market displacement through accidental market design.

The ongoing consolidation will stabilize the structure without changing the outcome. When 1,398 dispensaries rationalize to a sustainable number — perhaps 400–600 over the next three years — the survivors will have better margins, similar pricing, and a permanent competitive moat against illicit supply. The program that was never meant to function as adult use will keep functioning as adult use until the legislature decides to make it official.

This analysis applies the Dan K Reports Cannabis Market Framework. For methodology, assumptions, and the complete state-by-state comparison, see the framework documentation.